EE270 Predicting Persistent Severe Acute Kidney Injury (AKI) Using the Urinary C-C Motif Chemokine Ligand 14 Biomarker (CCL14). Cost-Utility Analysis in Spain and the UK
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.536
https://www.valueinhealthjournal.com/article/S1098-3015(23)03666-5/fulltext
Title :
EE270 Predicting Persistent Severe Acute Kidney Injury (AKI) Using the Urinary C-C Motif Chemokine Ligand 14 Biomarker (CCL14). Cost-Utility Analysis in Spain and the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03666-5&doi=10.1016/j.jval.2023.09.536
First page :
Section Title :
Open access? :
No
Section Order :
10030